The Spectacular Rise of the Indian Pharmaceutical Industry

Over the second half of the 20th century, Indian pharmaceutical firms were nudged by government policies to focus on import substitution. To this end, they were encouraged to produce generic variants of foreign MNEs’ branded drugs. In response, MNE strategies in India became strongly focused on intellectual property (IP) protection, most typically implemented through the avoidance of collaboration with domestic firms. Hence, domestic firms in...